[Preferential tumoral phototoxicity of chloroaluminum phthalocyanine in photodynamic therapy of human leukemic cells].
Daziano
J P
JP
Laboratoire Activation, Mécanismes, Marseille, France.
Humeau
L
L
Chabannon
C
C
Mannoni
P
P
Julliard
M
M
D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity*; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy / Q000473:pathology*; D007963:Leukocytes, Mononuclear; D009942:Organometallic Compounds / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity*; D010778:Photochemotherapy; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D007211:Indoles; D009942:Organometallic Compounds; D011838:Radiation-Sensitizing Agents; C044797:chloroaluminum phthalocyanine
Phototoxicité tumorale préférentielle de la chlorophtalocyanine d'aluminium en photothérapie dynamique de cellules leucémiques humaines.